Vaccine to Suppress Type 1 Onset in At-Risk Children Could Be Based on Enzyme

Unlike most vaccines, which work by “teaching” the immune system to attack something, this one would instruct it to avoid attacking pancreatic beta cells—the haywire autoimmune response responsible for the onset of type 1.

Feb 25, 2009

Georgia researchers believe that a powerful enzyme that inhibits or modifies immune system response could be the basis for a vaccine administered to children at high risk for developing type 1 diabetes.

Unlike most vaccines, which work by "teaching" the immune system to attack something, this one would instruct it to avoid attacking pancreatic beta cells-the haywire autoimmune response responsible for the onset of type 1.  

The enzyme, called indoleomine 2,3-dioxegenase (IDO), is an immune system inhibitor that fetuses use to fend off or prevent an immune response directed against them by their mothers' bodies. 

In their experiments with IDO, scientists at the Medical College of Georgia Immunotherapy Center in Augusta bundled the enzyme with dendritic cells, which are the cells that "tell" the body's powerful T cells to launch an attack.  Apparently the dendritic cells' association with IDO was enough to keep the body's powerful immune system warriors pacified.

Children at risk of developing type 1 do not have any or enough IDO associated with their dendritic cells, which leads them to invite T cell attacks on pancreatic beta cells. A vaccine that could increase dendritic cells' association with IDO would prevent, perhaps permanently, the T cell attack that eventually destroys the insulin-producing capability in patients' pancreases and signals the onset of type 1.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Insulin, Kids & Teens, Medications, Medications Research, Type 1 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.